Kaye I. Foster-Cheek - Jun 21, 2023 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role
Director
Signature
/s/ William Cook, as Attorney-in-fact for Kaye Foster
Stock symbol
AGIO
Transactions as of
Jun 21, 2023
Transactions value $
$0
Form type
4
Date filed
6/23/2023, 04:38 PM
Previous filing
Jun 16, 2023
Next filing
Aug 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGIO Common stock Options Exercise $0 +4.98K +75.97% $0.00 11.5K Jun 21, 2023 Direct
holding AGIO Common stock 2.2K Jun 21, 2023 By Foster Family Revocable Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGIO Restricted stock unit Options Exercise $0 -4.98K -100% $0.00* 0 Jun 21, 2023 Common stock 4.98K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Foster Family Revocable Trust, of which the reporting person is trustee and the reporting person and members of her immediate family are beneficiaries.
F2 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F3 The restricted stock units were granted on June 21, 2022. The shares underlying the stock units will vest in full on June 21, 2023. Vested shares will be delivered to the reporting person within three business days after such shares become vested.